Skip to main content
. 2023 Jan 15;15(2):531. doi: 10.3390/cancers15020531

Figure 13.

Figure 13

Nitrogen labeling from (amide)-15N-Gln in adenylosuccinate (a), adenosine monophosphate (AMP) (b), guanosine metabolites (c), asparagine (d), cytidine metabolites (e), and uridine metabolites (f) were significantly decreased by specific GLS inhibitor CB-839 in human GBM T98G cells. The samples were run in triplicate. For more details, see Section 2. * p < 0.05, **** p < 0.0001.